Publicaciones en las que colabora con Juan Luis Muñoz Bellido (38)

2018

  1. Management of cystic echinococcosis in the last two decades: What have we learned?

    Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 112, Núm. 5, pp. 207-215

2017

  1. Recurrence of cystic echinococcosis in an endemic area: A retrospective study

    BMC Infectious Diseases, Vol. 17, Núm. 1

2013

  1. ¿podemos pautar tratamiento empírico para infecciones del tracto urinario en nuestra área siguiendo las recomendaciones de las recientes guías clínicas?

    Revista Espanola de Quimioterapia

2012

  1. Reliability of MALDI-TOF mass spectrometry in the identification of anaerobic bacteria

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 10, pp. 597-601

2011

  1. Microorganisms direct identification from blood culture by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

    Clinical Microbiology and Infection, Vol. 17, Núm. 4, pp. 546-551

1995

  1. Antimicrobial resistance in Anaerobic bacteria: Current situation

    Anaerobe, Vol. 1, Núm. 2, pp. 69-80

  2. Oral cephalosporins: current perspectives

    International Journal of Antimicrobial Agents, Vol. 5, Núm. 4, pp. 231-243

1994

  1. In vitro activity of fosfomycin trometamol against urinary tract pathogens

    Revista Espanola de Quimioterapia, Vol. 7, Núm. 2, pp. 123-130

1992

  1. Current status of bacterial resistance to third-generation cephalosporins

    Diagnostic Microbiology and Infectious Disease, Vol. 15, Núm. 1, pp. 67-72

  2. FACTORES EPIDEMIOLOGICOS Y MODIFICACIONES DE LA FLORA VAGINAL EN LA BACTERIOSIS VAGINAL (VAGINOSIS BACTERIANA)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 10, Núm. 6, pp. 340-344

1991

  1. Antibiotic susceptibility profile of Xanthomonas maltophilia in vitro activity of β-lactam/β-lactamase inhibitor combinations

    Diagnostic Microbiology and Infectious Disease, Vol. 14, Núm. 3, pp. 239-243

  2. Case report

    Infectious Diseases Newsletter, Vol. 10, Núm. 1, pp. 6-7

  3. Improved tween 80 hydrolysis method for identification of Moraxella (Branhamella)catarrhalis

    European Journal of Clinical Microbiology & Infectious Diseases

  4. In vitro activity of six antacids and a urease inhibitor against Helicobacter pylori

    Revista Espanola de Quimioterapia

  5. In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia

    Journal of Chemotherapy, Vol. 3, Núm. 3, pp. 143-146

  6. Rapid diagnosis of Xanthomonas maltophilia

    Revista Espanola de Quimioterapia, Vol. 4, Núm. 4, pp. 333-335

  7. UTILIDAD DE UN NUEVO SISTEMA AUTOMATIZADO DE HEMOCULTIVO CON RESINAS ADSORBENTES PARA LA DETECCION DE BACTERIEMIAS EN PACIENTES HEMATOLOGICOS

    Revista Espanola de Microbiologia Clinica, Vol. 6, Núm. 8, pp. 377-380

1990

  1. Characteristics of Helicobacter (Campylobacter) pylori infection in our field

    Medicina clínica, Vol. 95, Núm. 17, pp. 648-652

  2. Ethiology and therapeutics of chronic infectious diseases of the ear in adults

    Revista Espanola de Quimioterapia, Vol. 3, Núm. 4, pp. 363-369

  3. In vitro activities of irloxacin and E-3846, two new quinolones

    Antimicrobial Agents and Chemotherapy, Vol. 34, Núm. 6, pp. 1262-1267